Neovacs S.A Operating margin
What is the Operating margin of Neovacs S.A?
The Operating margin of Neovacs S.A. is -12,000.00%
What is the definition of Operating margin?
Operating margin is the ratio of operating income divided by net sales and presented in percent.
ttm (trailing twelve months)
Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.
Operating margin of companies in the Health Care sector on EURONEXT compared to Neovacs S.A
What does Neovacs S.A do?
Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.
Companies with operating margin similar to Neovacs S.A
- BrainChip Ltd has Operating margin of -12,387.93%
- Stavely Minerals has Operating margin of -12,305.56%
- Key Petroleum has Operating margin of -12,250.00%
- Aurora Labs has Operating margin of -12,061.49%
- Constellation Resources has Operating margin of -12,049.12%
- Ovid Therapeutics Inc has Operating margin of -12,008.28%
- Neovacs S.A has Operating margin of -12,000.00%
- Verb Technology has Operating margin of -11,788.24%
- Albion Resources Ltd has Operating margin of -11,571.46%
- Golden Mile Resources has Operating margin of -11,516.67%
- Internet of Things has Operating margin of -11,511.14%
- Predictiv AI has Operating margin of -11,511.14%
- genedrive plc has Operating margin of -11,459.18%